AGP Executive Report
Last update: 2 hours agoMotivated Fact-Checking: A new study challenges the idea that partisan people reject uncomfortable political facts mainly to manage emotions, suggesting the bias runs deeper than simple mood control. Digital Identity & Biometrics: Regulators and researchers clash over how biometric data can be used in EU digital ID wallets, raising concerns that misaligned rules could weaken the EUDI Wallet rollout. Health & Weight-Loss Drugs: Novo Nordisk is sharing fresh semaglutide data at ADA 2026, while its next-gen candidate zenagamtide reports up to 14.6% weight loss in phase 2b for type 2 diabetes. Clinical Trial Setback: Low-dose naltrexone failed to beat placebo for fibromyalgia pain at EULAR 2026, though patient belief in treatment still correlated with some symptom improvements. EU Policy Pressure: The European Commission urges Germany to phase out Schengen internal border checks, arguing alternatives can handle migration and security needs. Denmark’s Defence Tech: The US approved a potential $842m sale of JASSM-ER cruise missiles to Denmark, boosting long-range strike capability for F-35s. Arctic Geopolitics: Experts warn Russia could use control of the “Bear Gap” Arctic route to threaten NATO and the UK with long-range strike risk. Data Centres in the Region: Gul Ahmed’s QGDC plans a $230m Pakistan Tier III data centre with Huawei, aiming to expand local AI and cloud capacity.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
